Advertisement

Topics

Enviro-Sciences, Inc. Company Profile

06:31 EDT 24th September 2017 | BioPortfolio

Enviro-Sciences, Inc. (ESI) provides value-added consulting and construction services to environmental, health, safety, and facility infrastructure problems and challenges. Founded in 1975, ESI remains dedicated to maintaining an entrepreneurial workplace that rewards the solving of clients' problems with innovative solutions. We embrace risk taking as an integral tool in aligning our interests with those of our clients. In a marketplace where many services are treated as commodities, ESI probes for fresh ideas that provide broader and greater value. We measure our success by the success our efforts bring to our clients.

Location

111 Howard Blvd., Suite 108
Mt. Arlington
New Jersey
07856
United States of America

Contact

Phone: (973) 398-8183
Fax: (973) 398-8037
Email: info@enviro-sciences.com


News Articles [473 Associated News Articles listed on BioPortfolio]

Hollywood Reporter on Food Evolution: ‘Polished and provocative’, challenges ‘enviro-activist orthodoxy’

THYMOX™ Announces Enviro-Tech as Exclusive North American Distributor for Dairy Market

SHERBROOKE, Quebec, July 24, 2017 (GLOBE NEWSWIRE) Read more...

Health Impacts from Wireless, EMF, Cell Phone, and WiFi Radiation Discussed at Major Conference in May

Los Angeles, CA (PRWEB) May 10, 2017 Clear Light Ventures was founded by Peter Sullivan with a “mission to improve human heal...

CV Sciences, Inc. Announces Webcast for Investor Update Call

LAS VEGAS, NV--(Marketwired - September 11, 2017) -CV Sciences, Inc., ( OTCQB : CVSI) (the "Company," "CV Sciences," "our" or "we") Read more...

CV Sciences, Inc. Announces Commencement of IND preparation immediately following Pre-IND ...

LAS VEGAS, NV--(Marketwired - June 19, 2017) -CV Sciences, Inc. ( OTCQB : CVSI) (the "Company," "CV Sciences," "our" or "we"), today Read more...

CV Sciences, Inc. to Present at MJAC2017 InvestorsHub International Cannabis Conference

LAS VEGAS, NV--(Marketwired - August 28, 2017) -CV Sciences, Inc. ( OTCQB : CVSI) ("CV Sciences," "our" or "we"), is pleased to Read more...

CV Sciences, Inc. Highlights Recent Research Showing Cannabidiol May Reduce Relapses in ...

LAS VEGAS, NV--(Marketwired - August 15, 2017) -CV Sciences, Inc.( OTCQB : CVSI) (the "Company," "CV Sciences," "our" or "we") highlighted Read more...

Lords Committee Launches New Inquiry into Life Sciences and the Industrial Strategy

The House of Lords Science and Technology Committee invites contributions to its new inquiry - Life Sciences and the Industrial Strategy. The Government set out in its Industrial Strategy Green Paper ...

Clinical Trials [148 Associated Clinical Trials listed on BioPortfolio]

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

The purpose of this study is to evaluate the efficacy of AC-150 compared to vehicle and its components in the prevention of the signs and symptoms of allergic conjunctivitis in Enviro-CAC...

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1019 Associated Companies listed on BioPortfolio]

Enviro-Sciences, Inc.

Enviro-Sciences, Inc. (ESI) provides value-added consulting and construction services to environmental, health, safety, and facility infrastructure problems and challenges. Founded in 1975, ESI remain...

Enviro-Solutions

Enviro-Solutions is a leading manufacturer of Proven Green, environmentally preferable cleaning products. An ISO-9001 certified company, Enviro-Solutions was established in...

SRP Enviro Systems

SRP Enviro Systems is a young organization, we bring with us a rich experience in the field of simulation, treatment and control of indoor air. We are, what we term as specialists in "In-vironment" co...

New Wave Enviro Products Inc.

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

More Information about "Enviro-Sciences, Inc." on BioPortfolio

We have published hundreds of Enviro-Sciences, Inc. news stories on BioPortfolio along with dozens of Enviro-Sciences, Inc. Clinical Trials and PubMed Articles about Enviro-Sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Enviro-Sciences, Inc. Companies in our database. You can also find out about relevant Enviro-Sciences, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record